Zobrazeno 1 - 10
of 18
pro vyhledávání: '"Th Werfel"'
Publikováno v:
Der Hautarzt. 69:210-216
Atopic eczema is a chronic recurrent inflammatory skin disease characterized by intensive pruritus and a high burden of disease. Based on a genetically determined skin barrier dysfunction, xerosis cutis and a tendency towards microbial skin infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::355d515a0709560a6c2459b836ae190b
https://doi.org/10.1007/s00105-018-4135-4
https://doi.org/10.1007/s00105-018-4135-4
Publikováno v:
Alergologia Polska - Polish Journal of Allergology. 4:2-6
Action Plan B3 of the European Innovation Partnership on Active and Healthy Ageing (EIP on AHA) focuses on the integrated care of chronic diseases. Area 5 (Care Pathways) was initiated using chronic respiratory diseases as a model. The chronic respir
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::e658eb2adb762922e6afb1fbe966cba7
https://doi.org/10.1016/j.alergo.2017.02.002
https://doi.org/10.1016/j.alergo.2017.02.002
Publikováno v:
Der Hautarzt; Zeitschrift fur Dermatologie, Venerologie, und verwandte Gebiete. 69(3)
Atopic eczema is a chronic recurrent inflammatory skin disease characterized by intensive pruritus and a high burden of disease. Based on a genetically determined skin barrier dysfunction, xerosis cutis and a tendency towards microbial skin infection
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=pmid________::ca57ac7a6528c0e79adf4b36ca899e91
https://pubmed.ncbi.nlm.nih.gov/29487960
https://pubmed.ncbi.nlm.nih.gov/29487960
Autor:
Th. Werfel
Publikováno v:
Allergologie. 36:537-538
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::1d83117b26db58ebff0c2d19cfeed17a
https://doi.org/10.5414/alx01640
https://doi.org/10.5414/alx01640
Autor:
Th. Werfel
Publikováno v:
Allergologie. 33:1-2
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::a1c77f937b518263aa00d487255b6f58
https://doi.org/10.5414/alp33001
https://doi.org/10.5414/alp33001
Publikováno v:
Archives of dermatological research. 289(2)
The expression of the receptor for the anaphylatoxin C5a on mast cells was studied with three monoclonal antibodies directed to the N-terminal domain of the C5a receptor. Human skin was investigated by immunohistology applied to sequential 2 μm sect
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8326f8ebf75d26d689ee35325579880f
https://pubmed.ncbi.nlm.nih.gov/9049041
https://pubmed.ncbi.nlm.nih.gov/9049041
Autor:
U. Essig, W. Beuche, M. Schulze, Martin Oppermann, E. Hempelmann, S. Lenzner, R. Würzner, H. Xu, H. Baumgarten, Th. Werfel, U. Friedrichs, M. Denden, T. Hebell, M. Grol, S. Schiefer, J. Endl, R. S. Thomas, J. H. Peters, Living Cells
Publikováno v:
Monoclonal Antibodies ISBN: 9783642745348
The answer to this question is trivial, but to the point: one can only find the correct antibody if the correct test system is used.
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4a7b46c074674698a4ba71adaf9c453a
https://doi.org/10.1007/978-3-642-74532-4_10
https://doi.org/10.1007/978-3-642-74532-4_10
Autor:
R. Würzner, H. Baumgarten, D. Baron, B. Goller, S. Lenzner, Th. Werfel, R. K. H. Gieseler, J. H. Peters
Publikováno v:
Monoclonal Antibodies ISBN: 9783642745348
To be suitable for fusion, myeloma and other tumor cells must fulfil the following four conditions: 1. They may no longer synthesize intact antibody or immunoglobulin light or heavy chains themselves. 2. They must possess an enzyme defect, to allow t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c3d826d7b31ed355709300db84adf5c0
https://doi.org/10.1007/978-3-642-74532-4_6
https://doi.org/10.1007/978-3-642-74532-4_6
Autor:
J. H. Peters, R. K. H. Gieseler, Th. Werfel, S. Lenzner, R. Würzner, H. Baumgarten, D. Baron, B. Goller
Publikováno v:
Monoklonale Antikörper ISBN: 9783540508441
Zur Fusion geeignete Myelom- und andere Tumorlinien mussen die folgenden 4 Bedingungen erfullen: 1. Sie durfen selbst keine kompletten Antikorper oder Immunglobulin-Leicht- oder Schwerketten mehr synthetisieren. 2. Sie sollen einen Enzymdefekt haben,
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::c95dcff16d1bc0a27975e43d5c0ce6bc
https://doi.org/10.1007/978-3-662-08842-5_6
https://doi.org/10.1007/978-3-662-08842-5_6
Autor:
M. Grol, U. Essig, Reinhold E. Schmidt, M. Schulze, P. A. T. Tetteroo, H. Xu, S. Lenzner, J. H. Peters, Th. Werfel, R. Würzner, Martin Oppermann, H. Baumgarten, T. Hebell, A. Neeleman, M. Denden, R. S. Thomas, S. Schiefer, W. Beuche, J. Endl, E. Hempelmann
Publikováno v:
Monoklonale Antikörper ISBN: 9783540508441
Die Antwort auf die gestellte Frage ist ebenso trivial wie treffend: Man kann nur dann den richtigen Antikorper finden, wenn das richtige Testsystem eingesetzt wird!
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::2b9dd656422ea9a4de440947c4422c84
https://doi.org/10.1007/978-3-662-08842-5_10
https://doi.org/10.1007/978-3-662-08842-5_10